nodes	percent_of_prediction	percent_of_DWPC	metapath
Minaprine—MAOA—conduct disorder	0.421	0.467	CbGaD
Minaprine—SLC6A4—conduct disorder	0.271	0.301	CbGaD
Minaprine—HTR2A—conduct disorder	0.209	0.232	CbGaD
Minaprine—MAOA—Enzymatic degradation of Dopamine by monoamine oxidase—COMT—conduct disorder	0.00845	0.089	CbGpPWpGaD
Minaprine—MAOA—Clearance of dopamine—COMT—conduct disorder	0.00611	0.0644	CbGpPWpGaD
Minaprine—DRD1—Dopamine receptors—DRD4—conduct disorder	0.00498	0.0524	CbGpPWpGaD
Minaprine—Moclobemide—MAOA—conduct disorder	0.00394	1	CrCbGaD
Minaprine—DRD2—Dopamine receptors—DRD4—conduct disorder	0.00376	0.0396	CbGpPWpGaD
Minaprine—ACHE—Neurotransmitter Clearance In The Synaptic Cleft—COMT—conduct disorder	0.00296	0.0312	CbGpPWpGaD
Minaprine—ACHE—Neurotransmitter Clearance In The Synaptic Cleft—MAOA—conduct disorder	0.00294	0.0309	CbGpPWpGaD
Minaprine—MAOA—Serotonin Transporter Activity—SLC6A4—conduct disorder	0.00285	0.03	CbGpPWpGaD
Minaprine—MAOA—Neurotransmitter Clearance In The Synaptic Cleft—COMT—conduct disorder	0.00279	0.0294	CbGpPWpGaD
Minaprine—SLC6A4—Serotonin Transporter Activity—MAOA—conduct disorder	0.00262	0.0276	CbGpPWpGaD
Minaprine—MAOA—Dopamine metabolism—COMT—conduct disorder	0.00189	0.0199	CbGpPWpGaD
Minaprine—ACHE—Biogenic Amine Synthesis—COMT—conduct disorder	0.00179	0.0188	CbGpPWpGaD
Minaprine—ACHE—Biogenic Amine Synthesis—MAOA—conduct disorder	0.00178	0.0187	CbGpPWpGaD
Minaprine—HTR2B—Serotonin receptors—HTR2A—conduct disorder	0.00171	0.018	CbGpPWpGaD
Minaprine—MAOA—Biogenic Amine Synthesis—COMT—conduct disorder	0.00169	0.0178	CbGpPWpGaD
Minaprine—HTR2C—Serotonin receptors—HTR2A—conduct disorder	0.00138	0.0145	CbGpPWpGaD
Minaprine—ACHE—Monoamine Transport—SLC6A4—conduct disorder	0.00129	0.0136	CbGpPWpGaD
Minaprine—DRD2—Nicotine Activity on Dopaminergic Neurons—DRD4—conduct disorder	0.00119	0.0126	CbGpPWpGaD
Minaprine—HTR2B—Monoamine GPCRs—DRD4—conduct disorder	0.00117	0.0123	CbGpPWpGaD
Minaprine—HTR2B—Serotonin Receptor 2 and ELK-SRF/GATA4 signaling—HTR2A—conduct disorder	0.00114	0.012	CbGpPWpGaD
Minaprine—DRD1—Hypothetical Network for Drug Addiction—DRD4—conduct disorder	0.00113	0.0119	CbGpPWpGaD
Minaprine—DRD1—Monoamine GPCRs—DRD4—conduct disorder	0.0011	0.0116	CbGpPWpGaD
Minaprine—ACHE—Melatonin metabolism and effects—MAOA—conduct disorder	0.00105	0.011	CbGpPWpGaD
Minaprine—ACHE—Peptide hormone metabolism—CGA—conduct disorder	0.000989	0.0104	CbGpPWpGaD
Minaprine—HTR2B—Amine ligand-binding receptors—DRD4—conduct disorder	0.000981	0.0103	CbGpPWpGaD
Minaprine—HTR2C—Monoamine GPCRs—DRD4—conduct disorder	0.000941	0.00992	CbGpPWpGaD
Minaprine—DRD1—Amine ligand-binding receptors—DRD4—conduct disorder	0.000925	0.00974	CbGpPWpGaD
Minaprine—HTR2C—Serotonin Receptor 2 and ELK-SRF/GATA4 signaling—HTR2A—conduct disorder	0.000917	0.00966	CbGpPWpGaD
Minaprine—DRD2—Hypothetical Network for Drug Addiction—DRD4—conduct disorder	0.000851	0.00897	CbGpPWpGaD
Minaprine—DRD2—Monoamine GPCRs—DRD4—conduct disorder	0.000831	0.00875	CbGpPWpGaD
Minaprine—HTR2A—Monoamine GPCRs—DRD4—conduct disorder	0.000817	0.00861	CbGpPWpGaD
Minaprine—CHRM1—Monoamine GPCRs—DRD4—conduct disorder	0.000813	0.00856	CbGpPWpGaD
Minaprine—HTR2C—Amine ligand-binding receptors—DRD4—conduct disorder	0.000791	0.00833	CbGpPWpGaD
Minaprine—HTR2B—Monoamine GPCRs—HTR2A—conduct disorder	0.000761	0.00802	CbGpPWpGaD
Minaprine—DRD1—Monoamine GPCRs—HTR2A—conduct disorder	0.000718	0.00756	CbGpPWpGaD
Minaprine—DRD2—Amine ligand-binding receptors—DRD4—conduct disorder	0.000698	0.00736	CbGpPWpGaD
Minaprine—HTR2A—Amine ligand-binding receptors—DRD4—conduct disorder	0.000687	0.00724	CbGpPWpGaD
Minaprine—CHRM1—Amine ligand-binding receptors—DRD4—conduct disorder	0.000683	0.0072	CbGpPWpGaD
Minaprine—DRD1—G alpha (s) signalling events—CGA—conduct disorder	0.000681	0.00718	CbGpPWpGaD
Minaprine—HTR2B—Amine ligand-binding receptors—HTR2A—conduct disorder	0.00064	0.00674	CbGpPWpGaD
Minaprine—HTR2C—Monoamine GPCRs—HTR2A—conduct disorder	0.000614	0.00647	CbGpPWpGaD
Minaprine—DRD1—Amine ligand-binding receptors—HTR2A—conduct disorder	0.000603	0.00636	CbGpPWpGaD
Minaprine—DRD2—Monoamine GPCRs—HTR2A—conduct disorder	0.000542	0.00571	CbGpPWpGaD
Minaprine—CHRM1—Monoamine GPCRs—HTR2A—conduct disorder	0.00053	0.00559	CbGpPWpGaD
Minaprine—HTR2C—Amine ligand-binding receptors—HTR2A—conduct disorder	0.000516	0.00544	CbGpPWpGaD
Minaprine—ACHE—Transmission across Chemical Synapses—GABRA2—conduct disorder	0.000468	0.00493	CbGpPWpGaD
Minaprine—DRD2—Amine ligand-binding receptors—HTR2A—conduct disorder	0.000456	0.0048	CbGpPWpGaD
Minaprine—CHRM1—Amine ligand-binding receptors—HTR2A—conduct disorder	0.000446	0.0047	CbGpPWpGaD
Minaprine—MAOA—Transmission across Chemical Synapses—GABRA2—conduct disorder	0.000441	0.00465	CbGpPWpGaD
Minaprine—CYP2D6—Melatonin metabolism and effects—MAOA—conduct disorder	0.00043	0.00453	CbGpPWpGaD
Minaprine—HTR2A—GPCRs, Other—DRD4—conduct disorder	0.000363	0.00382	CbGpPWpGaD
Minaprine—ACHE—Neuronal System—GABRA2—conduct disorder	0.000359	0.00378	CbGpPWpGaD
Minaprine—CHRM1—Regulation of Actin Cytoskeleton—WASF1—conduct disorder	0.000348	0.00367	CbGpPWpGaD
Minaprine—HTR2B—Class A/1 (Rhodopsin-like receptors)—CGA—conduct disorder	0.000344	0.00363	CbGpPWpGaD
Minaprine—MAOA—SIDS Susceptibility Pathways—SLC6A4—conduct disorder	0.000342	0.0036	CbGpPWpGaD
Minaprine—MAOA—Neuronal System—GABRA2—conduct disorder	0.000338	0.00356	CbGpPWpGaD
Minaprine—DRD1—Class A/1 (Rhodopsin-like receptors)—CGA—conduct disorder	0.000325	0.00342	CbGpPWpGaD
Minaprine—SLC6A4—Circadian rythm related genes—DRD4—conduct disorder	0.00032	0.00337	CbGpPWpGaD
Minaprine—SLC6A4—SIDS Susceptibility Pathways—MAOA—conduct disorder	0.000314	0.0033	CbGpPWpGaD
Minaprine—HTR2C—Class A/1 (Rhodopsin-like receptors)—CGA—conduct disorder	0.000278	0.00293	CbGpPWpGaD
Minaprine—DRD1—Circadian rythm related genes—SLC6A4—conduct disorder	0.000276	0.0029	CbGpPWpGaD
Minaprine—HTR2B—GPCR ligand binding—CGA—conduct disorder	0.000262	0.00276	CbGpPWpGaD
Minaprine—DRD1—Circadian rythm related genes—DRD4—conduct disorder	0.000259	0.00273	CbGpPWpGaD
Minaprine—ACHE—ATF-2 transcription factor network—EP300—conduct disorder	0.000257	0.0027	CbGpPWpGaD
Minaprine—SLC6A4—SIDS Susceptibility Pathways—HTR2A—conduct disorder	0.000256	0.00269	CbGpPWpGaD
Minaprine—HTR2A—SIDS Susceptibility Pathways—SLC6A4—conduct disorder	0.000251	0.00264	CbGpPWpGaD
Minaprine—DRD1—GPCR ligand binding—CGA—conduct disorder	0.000247	0.00261	CbGpPWpGaD
Minaprine—DRD2—Class A/1 (Rhodopsin-like receptors)—CGA—conduct disorder	0.000245	0.00258	CbGpPWpGaD
Minaprine—HTR2A—Class A/1 (Rhodopsin-like receptors)—CGA—conduct disorder	0.000241	0.00254	CbGpPWpGaD
Minaprine—CHRM1—Class A/1 (Rhodopsin-like receptors)—CGA—conduct disorder	0.00024	0.00253	CbGpPWpGaD
Minaprine—MAOA—Biological oxidations—COMT—conduct disorder	0.000239	0.00252	CbGpPWpGaD
Minaprine—ACHE—Transmission across Chemical Synapses—COMT—conduct disorder	0.000225	0.00237	CbGpPWpGaD
Minaprine—HTR2B—GPCRs, Class A Rhodopsin-like—DRD4—conduct disorder	0.000225	0.00237	CbGpPWpGaD
Minaprine—ACHE—Transmission across Chemical Synapses—MAOA—conduct disorder	0.000224	0.00236	CbGpPWpGaD
Minaprine—ACHE—Metabolism of lipids and lipoproteins—CGA—conduct disorder	0.000216	0.00228	CbGpPWpGaD
Minaprine—DRD1—GPCRs, Class A Rhodopsin-like—DRD4—conduct disorder	0.000212	0.00224	CbGpPWpGaD
Minaprine—MAOA—Transmission across Chemical Synapses—COMT—conduct disorder	0.000212	0.00224	CbGpPWpGaD
Minaprine—HTR2C—GPCR ligand binding—CGA—conduct disorder	0.000212	0.00223	CbGpPWpGaD
Minaprine—MAOA—SIDS Susceptibility Pathways—HTR2A—conduct disorder	0.00021	0.00221	CbGpPWpGaD
Minaprine—DRD2—Circadian rythm related genes—SLC6A4—conduct disorder	0.000208	0.00219	CbGpPWpGaD
Minaprine—CHRM1—Circadian rythm related genes—SLC6A4—conduct disorder	0.000204	0.00215	CbGpPWpGaD
Minaprine—DRD2—Circadian rythm related genes—DRD4—conduct disorder	0.000196	0.00206	CbGpPWpGaD
Minaprine—CYP2D6—Phase 1 - Functionalization of compounds—MAOA—conduct disorder	0.000195	0.00205	CbGpPWpGaD
Minaprine—HTR2B—Class A/1 (Rhodopsin-like receptors)—DRD4—conduct disorder	0.000193	0.00203	CbGpPWpGaD
Minaprine—CHRM1—Circadian rythm related genes—DRD4—conduct disorder	0.000192	0.00202	CbGpPWpGaD
Minaprine—HTR2B—G alpha (q) signalling events—HTR2A—conduct disorder	0.00019	0.002	CbGpPWpGaD
Minaprine—HTR2A—SIDS Susceptibility Pathways—MAOA—conduct disorder	0.000189	0.00199	CbGpPWpGaD
Minaprine—ACHE—Metabolism of proteins—CGA—conduct disorder	0.000187	0.00197	CbGpPWpGaD
Minaprine—DRD2—GPCR ligand binding—CGA—conduct disorder	0.000187	0.00197	CbGpPWpGaD
Minaprine—HTR2A—GPCR ligand binding—CGA—conduct disorder	0.000184	0.00194	CbGpPWpGaD
Minaprine—CHRM1—GPCR ligand binding—CGA—conduct disorder	0.000183	0.00193	CbGpPWpGaD
Minaprine—DRD1—Class A/1 (Rhodopsin-like receptors)—DRD4—conduct disorder	0.000182	0.00192	CbGpPWpGaD
Minaprine—HTR2C—GPCRs, Class A Rhodopsin-like—DRD4—conduct disorder	0.000182	0.00191	CbGpPWpGaD
Minaprine—DRD2—G alpha (i) signalling events—DRD4—conduct disorder	0.000173	0.00182	CbGpPWpGaD
Minaprine—ACHE—Neuronal System—COMT—conduct disorder	0.000173	0.00182	CbGpPWpGaD
Minaprine—ACHE—Neuronal System—MAOA—conduct disorder	0.000171	0.00181	CbGpPWpGaD
Minaprine—HTR2B—Gastrin-CREB signalling pathway via PKC and MAPK—HTR2A—conduct disorder	0.00017	0.00179	CbGpPWpGaD
Minaprine—MAOA—Neuronal System—COMT—conduct disorder	0.000163	0.00171	CbGpPWpGaD
Minaprine—DRD2—GPCRs, Class A Rhodopsin-like—DRD4—conduct disorder	0.00016	0.00169	CbGpPWpGaD
Minaprine—HTR2A—GPCRs, Class A Rhodopsin-like—DRD4—conduct disorder	0.000158	0.00166	CbGpPWpGaD
Minaprine—CHRM1—GPCRs, Class A Rhodopsin-like—DRD4—conduct disorder	0.000157	0.00165	CbGpPWpGaD
Minaprine—HTR2C—Class A/1 (Rhodopsin-like receptors)—DRD4—conduct disorder	0.000156	0.00164	CbGpPWpGaD
Minaprine—HTR2C—G alpha (q) signalling events—HTR2A—conduct disorder	0.000153	0.00162	CbGpPWpGaD
Minaprine—HTR2B—GPCR downstream signaling—CGA—conduct disorder	0.000148	0.00156	CbGpPWpGaD
Minaprine—HTR2B—GPCRs, Class A Rhodopsin-like—HTR2A—conduct disorder	0.000147	0.00155	CbGpPWpGaD
Minaprine—HTR2B—GPCR ligand binding—DRD4—conduct disorder	0.000147	0.00155	CbGpPWpGaD
Minaprine—DRD1—GPCR downstream signaling—CGA—conduct disorder	0.00014	0.00147	CbGpPWpGaD
Minaprine—DRD1—GPCRs, Class A Rhodopsin-like—HTR2A—conduct disorder	0.000139	0.00146	CbGpPWpGaD
Minaprine—DRD1—GPCR ligand binding—DRD4—conduct disorder	0.000139	0.00146	CbGpPWpGaD
Minaprine—DRD2—Class A/1 (Rhodopsin-like receptors)—DRD4—conduct disorder	0.000137	0.00145	CbGpPWpGaD
Minaprine—HTR2C—Gastrin-CREB signalling pathway via PKC and MAPK—HTR2A—conduct disorder	0.000137	0.00144	CbGpPWpGaD
Minaprine—SLC6A4—SIDS Susceptibility Pathways—EP300—conduct disorder	0.000135	0.00143	CbGpPWpGaD
Minaprine—HTR2A—Class A/1 (Rhodopsin-like receptors)—DRD4—conduct disorder	0.000135	0.00142	CbGpPWpGaD
Minaprine—HTR2B—Signaling by GPCR—CGA—conduct disorder	0.000135	0.00142	CbGpPWpGaD
Minaprine—CHRM1—Class A/1 (Rhodopsin-like receptors)—DRD4—conduct disorder	0.000134	0.00142	CbGpPWpGaD
Minaprine—CHRM1—G alpha (q) signalling events—HTR2A—conduct disorder	0.000132	0.00139	CbGpPWpGaD
Minaprine—DRD1—Signaling by GPCR—CGA—conduct disorder	0.000127	0.00134	CbGpPWpGaD
Minaprine—HTR2B—Class A/1 (Rhodopsin-like receptors)—HTR2A—conduct disorder	0.000126	0.00133	CbGpPWpGaD
Minaprine—HTR2C—GPCR downstream signaling—CGA—conduct disorder	0.00012	0.00126	CbGpPWpGaD
Minaprine—DRD1—Class A/1 (Rhodopsin-like receptors)—HTR2A—conduct disorder	0.000119	0.00125	CbGpPWpGaD
Minaprine—HTR2C—GPCRs, Class A Rhodopsin-like—HTR2A—conduct disorder	0.000118	0.00125	CbGpPWpGaD
Minaprine—HTR2C—GPCR ligand binding—DRD4—conduct disorder	0.000118	0.00125	CbGpPWpGaD
Minaprine—CHRM1—Gastrin-CREB signalling pathway via PKC and MAPK—HTR2A—conduct disorder	0.000118	0.00125	CbGpPWpGaD
Minaprine—MAOA—SIDS Susceptibility Pathways—EP300—conduct disorder	0.000111	0.00117	CbGpPWpGaD
Minaprine—SLC6A4—Circadian rythm related genes—EP300—conduct disorder	0.000111	0.00117	CbGpPWpGaD
Minaprine—HTR2C—Signaling by GPCR—CGA—conduct disorder	0.000109	0.00114	CbGpPWpGaD
Minaprine—DRD2—GPCR downstream signaling—CGA—conduct disorder	0.000106	0.00111	CbGpPWpGaD
Minaprine—DRD2—GPCRs, Class A Rhodopsin-like—HTR2A—conduct disorder	0.000105	0.0011	CbGpPWpGaD
Minaprine—DRD2—GPCR ligand binding—DRD4—conduct disorder	0.000105	0.0011	CbGpPWpGaD
Minaprine—CYP2D6—Biological oxidations—COMT—conduct disorder	0.000104	0.0011	CbGpPWpGaD
Minaprine—HTR2A—GPCR downstream signaling—CGA—conduct disorder	0.000104	0.00109	CbGpPWpGaD
Minaprine—CYP2D6—Biological oxidations—MAOA—conduct disorder	0.000104	0.00109	CbGpPWpGaD
Minaprine—CHRM1—GPCR downstream signaling—CGA—conduct disorder	0.000103	0.00109	CbGpPWpGaD
Minaprine—HTR2A—GPCR ligand binding—DRD4—conduct disorder	0.000103	0.00108	CbGpPWpGaD
Minaprine—CYP2D6—Metapathway biotransformation—COMT—conduct disorder	0.000103	0.00108	CbGpPWpGaD
Minaprine—CHRM1—GPCRs, Class A Rhodopsin-like—HTR2A—conduct disorder	0.000102	0.00108	CbGpPWpGaD
Minaprine—CHRM1—GPCR ligand binding—DRD4—conduct disorder	0.000102	0.00108	CbGpPWpGaD
Minaprine—HTR2C—Class A/1 (Rhodopsin-like receptors)—HTR2A—conduct disorder	0.000102	0.00107	CbGpPWpGaD
Minaprine—ACHE—Integrated Pancreatic Cancer Pathway—EP300—conduct disorder	0.0001	0.00106	CbGpPWpGaD
Minaprine—ACHE—Metabolism—CGA—conduct disorder	9.63e-05	0.00101	CbGpPWpGaD
Minaprine—DRD2—Signaling by GPCR—CGA—conduct disorder	9.58e-05	0.00101	CbGpPWpGaD
Minaprine—HTR2B—GPCR ligand binding—HTR2A—conduct disorder	9.58e-05	0.00101	CbGpPWpGaD
Minaprine—HTR2A—Signaling by GPCR—CGA—conduct disorder	9.43e-05	0.000993	CbGpPWpGaD
Minaprine—CHRM1—Signaling by GPCR—CGA—conduct disorder	9.38e-05	0.000988	CbGpPWpGaD
Minaprine—MAOA—Metabolism—CGA—conduct disorder	9.07e-05	0.000956	CbGpPWpGaD
Minaprine—DRD1—GPCR ligand binding—HTR2A—conduct disorder	9.04e-05	0.000952	CbGpPWpGaD
Minaprine—DRD1—Circadian rythm related genes—EP300—conduct disorder	8.96e-05	0.000944	CbGpPWpGaD
Minaprine—DRD2—Class A/1 (Rhodopsin-like receptors)—HTR2A—conduct disorder	8.96e-05	0.000944	CbGpPWpGaD
Minaprine—CHRM1—Class A/1 (Rhodopsin-like receptors)—HTR2A—conduct disorder	8.77e-05	0.000924	CbGpPWpGaD
Minaprine—HTR2B—GPCR downstream signaling—DRD4—conduct disorder	8.3e-05	0.000874	CbGpPWpGaD
Minaprine—HTR2A—SIDS Susceptibility Pathways—EP300—conduct disorder	8.15e-05	0.000859	CbGpPWpGaD
Minaprine—HTR2B—Signaling Pathways—CGA—conduct disorder	7.95e-05	0.000838	CbGpPWpGaD
Minaprine—DRD1—GPCR downstream signaling—DRD4—conduct disorder	7.83e-05	0.000825	CbGpPWpGaD
Minaprine—HTR2C—GPCR ligand binding—HTR2A—conduct disorder	7.73e-05	0.000815	CbGpPWpGaD
Minaprine—HTR2B—Signaling by GPCR—DRD4—conduct disorder	7.54e-05	0.000794	CbGpPWpGaD
Minaprine—DRD1—Signaling Pathways—CGA—conduct disorder	7.5e-05	0.00079	CbGpPWpGaD
Minaprine—DRD1—Signaling by GPCR—DRD4—conduct disorder	7.11e-05	0.000749	CbGpPWpGaD
Minaprine—DRD2—GPCR ligand binding—HTR2A—conduct disorder	6.82e-05	0.000719	CbGpPWpGaD
Minaprine—DRD2—Circadian rythm related genes—EP300—conduct disorder	6.77e-05	0.000713	CbGpPWpGaD
Minaprine—HTR2C—GPCR downstream signaling—DRD4—conduct disorder	6.7e-05	0.000705	CbGpPWpGaD
Minaprine—CHRM1—GPCR ligand binding—HTR2A—conduct disorder	6.68e-05	0.000704	CbGpPWpGaD
Minaprine—CHRM1—Circadian rythm related genes—EP300—conduct disorder	6.62e-05	0.000698	CbGpPWpGaD
Minaprine—HTR2C—Signaling Pathways—CGA—conduct disorder	6.41e-05	0.000676	CbGpPWpGaD
Minaprine—HTR2B—Signaling Pathways—WASF1—conduct disorder	6.37e-05	0.000671	CbGpPWpGaD
Minaprine—HTR2C—Signaling by GPCR—DRD4—conduct disorder	6.08e-05	0.000641	CbGpPWpGaD
Minaprine—DRD1—Signaling Pathways—WASF1—conduct disorder	6.01e-05	0.000633	CbGpPWpGaD
Minaprine—DRD2—GPCR downstream signaling—DRD4—conduct disorder	5.91e-05	0.000623	CbGpPWpGaD
Minaprine—HTR2A—GPCR downstream signaling—DRD4—conduct disorder	5.81e-05	0.000613	CbGpPWpGaD
Minaprine—CHRM1—GPCR downstream signaling—DRD4—conduct disorder	5.78e-05	0.000609	CbGpPWpGaD
Minaprine—DRD2—Signaling Pathways—CGA—conduct disorder	5.66e-05	0.000596	CbGpPWpGaD
Minaprine—HTR2A—Signaling Pathways—CGA—conduct disorder	5.57e-05	0.000587	CbGpPWpGaD
Minaprine—CHRM1—Signaling Pathways—CGA—conduct disorder	5.54e-05	0.000584	CbGpPWpGaD
Minaprine—HTR2B—GPCR downstream signaling—HTR2A—conduct disorder	5.42e-05	0.000571	CbGpPWpGaD
Minaprine—DRD2—Signaling by GPCR—DRD4—conduct disorder	5.37e-05	0.000565	CbGpPWpGaD
Minaprine—HTR2A—Signaling by GPCR—DRD4—conduct disorder	5.28e-05	0.000556	CbGpPWpGaD
Minaprine—CHRM1—Signaling by GPCR—DRD4—conduct disorder	5.25e-05	0.000553	CbGpPWpGaD
Minaprine—HTR2C—Signaling Pathways—WASF1—conduct disorder	5.14e-05	0.000542	CbGpPWpGaD
Minaprine—DRD1—GPCR downstream signaling—HTR2A—conduct disorder	5.11e-05	0.000538	CbGpPWpGaD
Minaprine—HTR2B—Signaling by GPCR—HTR2A—conduct disorder	4.92e-05	0.000518	CbGpPWpGaD
Minaprine—DRD1—Signaling by GPCR—HTR2A—conduct disorder	4.64e-05	0.000489	CbGpPWpGaD
Minaprine—DRD2—Signaling Pathways—WASF1—conduct disorder	4.54e-05	0.000478	CbGpPWpGaD
Minaprine—HTR2A—Signaling Pathways—WASF1—conduct disorder	4.46e-05	0.00047	CbGpPWpGaD
Minaprine—HTR2B—Signaling Pathways—DRD4—conduct disorder	4.45e-05	0.000469	CbGpPWpGaD
Minaprine—CHRM1—Signaling Pathways—WASF1—conduct disorder	4.44e-05	0.000468	CbGpPWpGaD
Minaprine—HTR2C—GPCR downstream signaling—HTR2A—conduct disorder	4.37e-05	0.00046	CbGpPWpGaD
Minaprine—ACHE—Metabolism—COMT—conduct disorder	4.35e-05	0.000458	CbGpPWpGaD
Minaprine—ACHE—Metabolism—MAOA—conduct disorder	4.32e-05	0.000455	CbGpPWpGaD
Minaprine—DRD1—Signaling Pathways—DRD4—conduct disorder	4.2e-05	0.000442	CbGpPWpGaD
Minaprine—ACHE—Metabolism of lipids and lipoproteins—EP300—conduct disorder	4.19e-05	0.000441	CbGpPWpGaD
Minaprine—MAOA—Metabolism—COMT—conduct disorder	4.09e-05	0.000431	CbGpPWpGaD
Minaprine—HTR2C—Signaling by GPCR—HTR2A—conduct disorder	3.97e-05	0.000418	CbGpPWpGaD
Minaprine—CYP2D6—Metabolism—CGA—conduct disorder	3.95e-05	0.000416	CbGpPWpGaD
Minaprine—DRD2—GPCR downstream signaling—HTR2A—conduct disorder	3.86e-05	0.000406	CbGpPWpGaD
Minaprine—CHRM1—GPCR downstream signaling—HTR2A—conduct disorder	3.77e-05	0.000398	CbGpPWpGaD
Minaprine—HTR2C—Signaling Pathways—DRD4—conduct disorder	3.59e-05	0.000378	CbGpPWpGaD
Minaprine—DRD2—Signaling by GPCR—HTR2A—conduct disorder	3.5e-05	0.000369	CbGpPWpGaD
Minaprine—CHRM1—Signaling by GPCR—HTR2A—conduct disorder	3.43e-05	0.000361	CbGpPWpGaD
Minaprine—DRD2—Signaling Pathways—DRD4—conduct disorder	3.17e-05	0.000334	CbGpPWpGaD
Minaprine—HTR2A—Signaling Pathways—DRD4—conduct disorder	3.12e-05	0.000329	CbGpPWpGaD
Minaprine—CHRM1—Signaling Pathways—DRD4—conduct disorder	3.1e-05	0.000327	CbGpPWpGaD
Minaprine—HTR2B—Signaling Pathways—HTR2A—conduct disorder	2.91e-05	0.000306	CbGpPWpGaD
Minaprine—DRD1—Signaling Pathways—HTR2A—conduct disorder	2.74e-05	0.000289	CbGpPWpGaD
Minaprine—HTR2C—Signaling Pathways—HTR2A—conduct disorder	2.34e-05	0.000247	CbGpPWpGaD
Minaprine—DRD2—Signaling Pathways—HTR2A—conduct disorder	2.07e-05	0.000218	CbGpPWpGaD
Minaprine—CHRM1—Signaling Pathways—HTR2A—conduct disorder	2.02e-05	0.000213	CbGpPWpGaD
Minaprine—ACHE—Metabolism—EP300—conduct disorder	1.86e-05	0.000196	CbGpPWpGaD
Minaprine—CYP2D6—Metabolism—COMT—conduct disorder	1.78e-05	0.000188	CbGpPWpGaD
Minaprine—CYP2D6—Metabolism—MAOA—conduct disorder	1.77e-05	0.000186	CbGpPWpGaD
Minaprine—MAOA—Metabolism—EP300—conduct disorder	1.76e-05	0.000185	CbGpPWpGaD
Minaprine—HTR2B—Signaling Pathways—EP300—conduct disorder	1.54e-05	0.000162	CbGpPWpGaD
Minaprine—DRD1—Signaling Pathways—EP300—conduct disorder	1.45e-05	0.000153	CbGpPWpGaD
Minaprine—HTR2C—Signaling Pathways—EP300—conduct disorder	1.24e-05	0.000131	CbGpPWpGaD
Minaprine—DRD2—Signaling Pathways—EP300—conduct disorder	1.1e-05	0.000115	CbGpPWpGaD
Minaprine—HTR2A—Signaling Pathways—EP300—conduct disorder	1.08e-05	0.000114	CbGpPWpGaD
Minaprine—CHRM1—Signaling Pathways—EP300—conduct disorder	1.07e-05	0.000113	CbGpPWpGaD
Minaprine—CYP2D6—Metabolism—EP300—conduct disorder	7.64e-06	8.05e-05	CbGpPWpGaD
